Magnesium in chronic kidney disease;Magnesio en la enfermedad renal crónica

Nefrologia

Volumn 27, Issue 6, 2007, Pages 674-680

  Tapia, H ^a   Mora, C ^a   Navarro González, Juan F ^a  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM;

BLOOD; CHRONIC KIDNEY FAILURE; HOMEOSTASIS; HUMAN; METABOLIC DISORDER; METABOLISM; PHYSIOLOGY; REVIEW;

HOMEOSTASIS; HUMANS; KIDNEY FAILURE, CHRONIC; MAGNESIUM; METABOLIC DISEASES;

EID: 42949122704     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Slatopolsky E, Klahr F: Disorders of calcium, magnesium and phosphorus metabolism. En: Shrier RW, Gottschalk CW, editors. Diseases of the Kidney. Boston: Little Brown & Co.: 2902-20, 1988.
2. Sutton R, Dakhaee K: Magnesium balance and metabolism. En: Jacobson HR, Stirker GE, Klahr S, editors. The Principles and Practice of Nephrology. Philadelphia: B. C. Decker Inc: 136-9, 1991.
3. Lowenthal DT: Clinical pharmacology of magnesium chloride. En: Giles TD and Seelig MS, editors. The Role of Magnesium Chloride Therapy in Clinical Practice. Clifton: Oxford Health Care Inc: 9-10, 1998.
4. Alfrey AC, Miller NL: Bone magnesium pools in uremia. J Clin Invest 52: 3019-23, 1973.
5. Webster PO: Magnesium. Am J Clin Nutr 45: 1305-12, 1987.
6. Gunther T: Mechanisms of regulation of Mg2+ efflux and Mg2+ influx. Miner Electrolyte Metab 19: 259-65, 1993.
7. Speich M, Bousquet B, Nicolas G: Reference values for ionized, complexed, and protein-bound plasma magnesium in men and women. Clin Chem 27: 246-8, 1981.
8. Elin RJ: Magnesium metabolism in health and disease. Dis Month 34: 165-218, 1988.
9. 28 in man. Metabolism 9: 646-59, 1960.
10. Brannan PG, Bergne-Marini P, Pak CYC, Hull AR, Fodtran JS: Magnesium absorption in the human small intestine. J Clin Invest 57: 1412-18, 1996.
11. Kayne LH, Lee DBN: Intestinal magnesium absroption. Miner Electrolyte Metab 19: 210-7, 1993.
12. Spencer H, Lesniak M, Gatza CA, Osis D, Lender M: Magnesium absorption and metabolism in patients with chronic renal failure and in patients with normal renal function. Gastroenterology 79: 26-34, 1980.
13. Alfrey AC, Miller NL, Trow R: Effect of age and magnesium depletion on bone magnesium pools in rats. J Clin Invest 54: 1074-81, 1974.
14. Clarkson EM, McDonald SJ, DeWardener HE, Warren R: Magnesium metabolism in chronic renal failure. Clin Sci 28: 107-15, 1965.
15. Kopple JD, Coburn JW: Metabolic studies of low protein diets in uremia. II. Calcium, phosphorus, and magnesium. Medicine 52: 597-607, 1973.
16. Randall RE Jr: Magnesium metabolism in chronic renal disease. Ann NY Acad Sci 162: 831-46, 1969.
17. Mountokalakis TD, Virvidakis CE, Singhellakis PN, Alevizaki CC, Ikkos DC: Magnesium absorption in CRF. Gastroenterology 80: 632-5, 1981.
18. Spencer H, Osis D: Studies of magnesium metabolism in man. Magnesium 7: 271-80, 1988.
19. Mountokalakis TD, Virvidakis CF, Singhellakis PN, Alevizaki GG, Ikkos DG: Relationship between degree of renal failure and impairment of intestinal magnesium absorption. En: Cantin M, Seelig MS, editors. Magnesium in health and disease. New York and London: SP Medical and Scientific Books: 453: 8, 1980.
20. 3 on jejunal absorption of magnesium in patients with chronic renal failure. Am J Physiol 238: G349-G52, 1980.
21. McCance RA, Widdowson EM, Lehmann H: The effect of protein intake on the absorption of calcium and magnesium. Biochem J 36: 686-91, 1942.
22. Quamme GA, Dirks JH: Magnesium metabolism. En: Maxwell MH, Kleeman CR, Narins RG, editors. Disorders of Fluid and Electrolyte Metabolism. New York: McGraw-Hill: 297-316, 1987.
23. Quamme GA, De Rouffignac C: Transport of magnesium in renal epithelial cells. En: Birch NJ, editor. Magnesium and the Cell. London: Academic: 235-262, 1993.
24. Al-Ghamdi SM, Cameron EC, Sutton RA: Magnesium deficiency: pathophysiologic and clinical overview. Am J Kidney Dis 24: 737-52, 1994.
25. Lowenthal DT, Ruiz JG: Magnesium deficiency in the elderly. Geriatric Urol Nephrol 5: 105-111, 1995.
26. Quamme GA, Dirks JH.: The physiology of renal magnesium handling. Renal Physiol 9: 257-69, 1986.
27. Hu JF, Zhao XH, Parpia B, Campbell TC: Dietary intakes and urinary excretion of calcium and acids: a cross-sectional study of women in China. Am J Clin Nutr 58: 398-406, 1993.
28. Popovtzer MM, Schainuck LI, Massry SG, Kleeman CR: Divalent ion excretion in chronic kidney disease. Relation to degree of renal insufficiency. Clin Sci 38: 297-307, 1970.
29. Kesteloot H, Joosens JV: The relationship between dietary intake and urinary excretion of sodium, potassium, calcium and magnesium. J Hum Hypertens 4: 527-33, 1990.
30. Popovtzer MM, Massry SG, Coburn JW, Kleeman CR: The interrelationship between sodium, calcium and magensium excretion in advanced renal failure. J Lab Clin Med 73: 763-71, 1969.
31. Martínez-Maldonado M, Yium JJ, Suki WN, Eknoyan G: Electrolyte excretion in polycystic kidney disease. Interrelationship between sodium, calcium, magnesium and phosphate. J Lab Clin Med 90: 1066-1075, 1977.
32. Kleeman CR, Better OS: Disordered divalent ion metabolism in kidney disease. Comments on pathogenesis and treatment. Kidney Int 4: 73-79, 1973.
33. Mountokalakis TD: Magnesium metabolism in chronic renal failure. Magnes Res 3: 121-7, 1990.
34. Zaman F, Abreo K: Severe hypermagnesemia as a result of laxative use in renal insufficiency. South Med J 96: 102-3, 2003.
35. Schelling JR: Fatal hypermagnesemia. Clin Nephrol 53: 61-5, 2000.
36. Kopple MH, Massry SG, Shinaberger JH, Hartenbower DL, Coburn JW: Thiazide-induced rise in serum calcium and magnesium in patients on maintenance hemodialysis. Ann Intern Med 72: 895-901, 1970.
37. Sörensen E, Tougaard L, Bröchner-Mortensen J: Iatrogenic magnesium intoxication during 1-a-hydroxycholecalciferol treatment. Br Med J 2: 215, 1976.
38. Saha H, Harmoinen A, Pietilä K, Mörsky P, Pasternack A: Measurement of serum ionized versus total levels of magnesium and calcium in hemodialysis patients. Clin Nephrol 46: 326-31, 1996.
39. Navarro J, Mora C, Macía M, García J: Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients. Perit Dial Int 19: 455-61, 1999.
40. Gonella M, Moriconi L, Betti G, Bonaguidi F, Buzzigoli G, Bartolini V y cols.: Serum levels of PTH, Mg, Ca, inorganic phosphorus and alkaline phosphatase in uremic patients on different Mg dialysis. Proc Eur Dial Transplant Ass 17: 362-6, 1980.
41. Nilsson P, Johansson SG, Danielson BG: Magnesium studies in hemodialysis patients before and after treatment with low dialysate magnesium. Nephron 37: 25-9, 1984.
42. Kancir CB, Wanscher M: Effect of magnesium gradient concentration between plasma and dialysate on magnesium variations induced by hemodialysis. Magnesium 89: 132-6, 1989.
43. Nair KS, Holdaway IM, Evans MC, Cameron AD: Influence of Mg on the secretion and action of parathyroid hormone. J Endocrinol Invest 2: 267-70, 1979.
44. Vaporean ML, Van Stone JC: Dialysate magnesium. Sem Dialysis 6: 46-51, 1993.
45. Navarro J, Mora C, Jiménez A, Torres A, Macía M, García J: Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients. Am J Kidney Dis 34: 43-8, 1999.
46. Ahsan Ejaz A, McShane AP, Gandhi VC, Leehey DJ, Ing TS: Hypomagnesemia in continous ambulatory peritoneal dialysis patients dialyzed with a low-magnesium peritoneal dialysis solution. Perit Dial Int 15: 61-4, 1995.
47. Hutchinson AJ, Were AJ, Boulton HF, Mawer EB, Laing I, Gokal R: Hypercalcaemia, hypermagnesaemia, hyperphosphataemia and hyperaluminaemia in CAPD: improvement in serum biochemistry by reduction in dialysate calcium and magnesium concentrations. Nephron 75: 52-8, 1996.
48. Blumenkrantz JM, Kopple JD, Moran JK, Coburn JW: Metabolic balance studies and dietary protein requeriments in patients undergoing continous ambulatory peritoneal dialysis. Kidney Int 21: 849-61, 1982.
49. Nilsson P, Johanson SG, Danielson BG: Magnesium studies in hemodialysis patients before and after treatment with low dialysate magenesium. Nephron 37: 25-9, 1984.
50. Contiguglia SR, Alfrey AC, Miller N, Butkus D: Total-body magnesium excess in chronic renal failure. Lancet II: 1300-2, 1972.
51. Krender DA: hypermagnesemia and neuromuscular transmission. Semin Neurol 10: 42-7, 1990.
52. Agus ZS, Morad M: Modulation of cardiac ion channels by magnesium. Annu Rev Physiol 53: 299-305, 1991.
53. Massry SG, Coburn JW, Kleeman CR: Evidence for suppression of parathyroid gland activity by hypermagnesemia. J Clin Invest 49: 1619-29, 1970.
54. Meema HE, Oreopoulos DG, Rapoport A: Serum magnesium level and arterial calcification in end-stage renal disease. Kidney Int 32: 388-94, 1987.
55. Cisari C, Gasco P, Calabrese G, Pratesi G, Gonella M: Serum magnesium and nerve conduction velocity in uraemic patients on chronic haemodialysis. Magnes Res 2: 267-9, 1989.
56. Carmichael AJ, McHugh MM, Martin AM, Farrow M: Serlogical markers of renal itch in patients receiving lon term haemodialysis. Br Med J (Clin Res Ed) 296: 1575, 1988.
57. Graf H, Kovarik J, Stummvell HK, Wolf A: Disappearance of uraemic pruritus after lowering dialysate Mg concentration. Br Med J II:1478-9, 1979.
58. Carmichael AJ, Dickinson F, McHugh MI, Martin AM, Farrow M: Magnesium free dialysate for uraemic pruritus. Br Med J 297: 1584-5, 1988.
59. Felsenfeld AJ, Rodríguez M, Dunlay R, Llach F: A comparison of parathyroid-gland function in haemodialysis patients with different forms of renal osteodystrophy. Nephrol Dial Transplant 6: 244-51, 1991.
60. Sherrard D, Hercz G, Pei Y, Maloney N, Greenwood C, Manuel A, Saiphoo C y cols.: The spectrum of bone disease in end-stage renal failure - an evolving disorder. Kidney Int 43: 436-42, 1993.
61. Brautbar N, Gruber H: Magnesium and bone disease. Nephron 44: 1-7, 1986.
62. Blumenthal N, Posner A: Hydroxyapatite: mechanism of formation and properties. Calcif Tissue Res 13: 235-43, 1973.
63. Brunner FP, Thiel G: The use of magnesium-containing phosphate binders in patients with end-stage renal disease on maintenance haemodialysis. Nephron 32: 266, 1982.
64. Gonella M, Ballanti P, Della Roca C, Calabrese G, Pratesi G, Vagelli G y cols.: Improved bone morphology by normalizing serum magnesium in chronically hemodialyzed patients. Miner Electrolyte Metab 14: 240-5, 1988.
65. Termine J, Peckauskas R, Posner A: Calcium phosphate formation in vitro. II. Effects of environment on amorphous-crystalline transformation. Arch Biochem Biophys 140: 318-25, 1970.
66. Boskey A, Posner A: Effect of magnesium on lipid-induced calcification: an in vitro model for bone mineralization. Calcif Tissue Int 32: 139-43, 1980.
67. Drueke T: Does magnesium excess play a role in renal osteodystrophy? Contrib Nephrol 38: 195-204, 1984.
68. Ferment O, Garnier PE, Touitou Y: Comparison of the feedback effect of magnesium and calcium on parathyroid hormone secretion in man. J Endocrinology 113: 117-23, 1987.
69. Gough IR, Balderson GA, Lloyd HM, Galligan J, Willgoss D, Fryar BG: The effect of intravenous magnesium sulphate on parathyroid function in primary hyperparathyroidism. World J Surg 12: 463-69, 1988.
70. Mennes P, Rosenbaum R, Martin K, Slatopolski E: Hypomagnesemia and impaired parathyroid hormone secretion in chronic renal disease. Ann Intern Med 88: 206-209, 1978.
71. Lien JWK: Hypomagnesaemic hypocalcaemia in renal failure. Br Med J IV: 1400, 1978.
72. Miller PD, Krebs RA, Neal BJ, McIntyre DO: Hypomagnesemia supression of secondary hyperparathyroidism in chronic renal failure. JAMA 241: 953-5, 1979.
73. Kenny MA, Casillas E, Ahmad S: Magnesium, calcium and PTH relationship in dialysis patients after magnesium repletion. Nephron 46: 199, 1987.
74. O'Donovan R, Baldwin D, Hammer M, Moniz C: Substitution of aluminum salts by magnesium salts in control of dialysis hyperphosphataemia. Lancet 1: 880-2, 1986.
75. Moriniere P, Vinatier I, Westeel P, Cohemsolal M, Belbrik S, Abdulmassih Z y cols.: Magnesium hydroxide as a complementary aluminium-free phosphate binder to moderate doses of oral calcium in uraemic patients on chronic haemodialysis: lack of deleterious effect on bone mineralisation. Nephrol Dial Transplant 3: 651-6, 1988.
76. Delmez JA, Kelber J, Norword KY, Giles KS, Slatopolsky E: Magnesium carbonate as a phosphorus binder: a prospective, controlled, crossover study. Kidney Int 49: 163-7, 1996.
77. Parsons VA, Baldwin D, Moniz C, Marsden J, Ball E, Rifkin I: Successful control of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis using magnesium carbonate and calcium carbonate as phosphate binders. Nephron 63: 379-83, 1993.
78. Plekta P, Bernstein DS, Hampers CL, Merill JP, Sherwood LM: Relationship between magnesium and secondary hyperparathyroidism during long term hemodialysis. Metabolism 23: 619-24, 1974.
79. Oe PL, Lips P, Wan der Meulen J, De Bries PMJM, Van Bronswijk H, Donker ASM: Long term use of magnesium hydroxide as a phosphate binder in patients on hemodialysis. Clin Nephrol 28: 180-5, 1987.
80. Parsons V, Papapoulos E, Weston MJ, Tomlinson S, O'Riordan JLH: The long term effect of lowering dialysate magnesium on circulating parathyroid hormone in patients on regular hemodialysis therapy. Acta Endocrinol (Copenh) 93: 455-60, 1980.
81. Nilsson P, Johansson SG, Danielson BG: Magnesium studies in hemodialysis patients before and after treatment with low dialysate magnesium. Nephron 37: 25-9, 1984.
82. McGonigle R, Weston M, Keenan J, Jackson D, Parsons V: Effect of hypermagnesemia on circulating plasma parathyroid hormone in patients on regular hemodialysis therapy. Magnesium 3: 1-7, 1984.
83. Navarro JF, Macía ML, Gallego E, Méndez ML, Chahin J, García-Nieto V, García JJ: Serum magnesium concentration and PTH levels. Is long-term chronic hypermagnesemia a risk factor for acynamic bone disease? Scan J Urol Nephrol 31: 275-80, 1997.
84. Saha H, Harmoinen A, Pietilä K, Mörsky P, Pasternack A: Measurement of serum ionized versus total levels of magnesium and calcium in hemodialysis patients. Clin Nephrol 46: 326-31, 1996.